<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30194441</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>USP4 positively regulates RLR-induced NF-&#x3ba;B activation by targeting TRAF6 for K48-linked deubiquitination and inhibits enterovirus 71 replication.</ArticleTitle><Pagination><StartPage>13418</StartPage><MedlinePgn>13418</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13418</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-31734-6</ELocationID><Abstract><AbstractText>Retinoic acid-inducible gene I-like receptor (RLR) is one of the most important pattern recognition receptors of the innate immune system that detects positive and/or negative stranded RNA viruses. Subsequently, it stimulates downstream transcription of interferon regulatory factor 3 (IRF3) and nuclear factor &#x3ba;B (NF-&#x3ba;B) inducing the production of interferons (IFNs) and inflammatory cytokines. Tumour necrosis factor receptor associated factor 6 (TRAF6) is a key protein involved in the RLR-mediated antiviral signalling pathway, recruiting additional proteins to form a multiprotein complex capable of activating the NF-&#x3ba;B inflammatory pathway. Despite TRAF6 playing an important role in regulating host immunity and viral infection, the deubiquitination of TRAF6 induced by viral infection remains elusive. In this study, we found that enterovirus 71 (EV71) infection attenuated the expression of Ubiquitin-specific protease 4 (USP4) in vitro and in vivo, while overexpression of USP4 significantly suppressed EV71 replication. Furthermore, it was found that EV71 infection reduced the RLR signalling pathway and enhanced the degradation of TRAF6. USP4 was also found to interact with TRAF6 and positively regulate the RLR-induced NF-&#x3ba;B signalling pathway, inhibiting the replication of EV71. Therefore, as a novel positive regulator of TRAF6, USP4 plays an essential role in EV71 infection by deubiquitinating K48-linked ubiquitin chains.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiao-Peng</ForeName><Initials>XP</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Xiang-Min</ForeName><Initials>XM</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Wei-Feng</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, P. R. China. shiweifeng67@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048029">TNF Receptor-Associated Factor 6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000631106">TRAF6 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C082325">Usp4 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D064570">Ubiquitin-Specific Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C503356">Ddx58 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000071457">DEAD Box Protein 58</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Sci Rep. 2023 Jul 19;13(1):11670. doi: 10.1038/s41598-023-38726-1</RefSource><PMID Version="1">37468527</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071457" MajorTopicYN="N">DEAD Box Protein 58</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048029" MajorTopicYN="N">TNF Receptor-Associated Factor 6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064570" MajorTopicYN="N">Ubiquitin-Specific Proteases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="Y">Ubiquitination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30194441</ArticleId><ArticleId IdType="pmc">PMC6128947</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-31734-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-31734-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. The Lancet. Infectious diseases. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Enterovirus 71 inhibits cytoplasmic stress granule formation during the late stage of infection. Virus research. 2018;255:55&#x2013;67. doi: 10.1016/j.virusres.2018.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2018.07.006</ArticleId><ArticleId IdType="pubmed">30006004</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS microbiology reviews. 2002;26:91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CK, et al. Mutations in VP1 and 5&#x2032;-UTR affect enterovirus 71 virulence. Scientific reports. 2018;8:6688. doi: 10.1038/s41598-018-25091-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25091-7</ArticleId><ArticleId IdType="pmc">PMC5923339</ArticleId><ArticleId IdType="pubmed">29703921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. The Lancet. Neurology. 2010;9:1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, He ML. The virology and developments toward control of human enterovirus 71. Critical reviews in microbiology. 2011;37:313&#x2013;327. doi: 10.3109/1040841X.2011.580723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1040841X.2011.580723</ArticleId><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo YM, et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. Journal of virology. 2008;82:335&#x2013;345. doi: 10.1128/JVI.01080-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01080-07</ArticleId><ArticleId IdType="pmc">PMC2224404</ArticleId><ArticleId IdType="pubmed">17942531</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805&#x2013;820. doi: 10.1016/j.cell.2010.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.022</ArticleId><ArticleId IdType="pubmed">20303872</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo YM, Gale M., Jr. Immune signaling by RIG-I-like receptors. Immunity. 2011;34:680&#x2013;692. doi: 10.1016/j.immuni.2011.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.003</ArticleId><ArticleId IdType="pmc">PMC3177755</ArticleId><ArticleId IdType="pubmed">21616437</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annual review of immunology. 2009;27:519&#x2013;550. doi: 10.1146/annurev.immunol.021908.132612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132612</ArticleId><ArticleId IdType="pubmed">19302047</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong X, et al. Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection. BMC infectious diseases. 2012;12:224. doi: 10.1186/1471-2334-12-224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-224</ArticleId><ArticleId IdType="pmc">PMC3519709</ArticleId><ArticleId IdType="pubmed">22994237</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. EV71 3D Protein Binds with NLRP3 and Enhances the Assembly of Inflammasome Complex. PLoS pathogens. 2017;13:e1006123. doi: 10.1371/journal.ppat.1006123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006123</ArticleId><ArticleId IdType="pmc">PMC5245909</ArticleId><ArticleId IdType="pubmed">28060938</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths MJ, et al. In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1beta, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis. The Journal of infectious diseases. 2012;206:881&#x2013;892. doi: 10.1093/infdis/jis446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis446</ArticleId><ArticleId IdType="pubmed">22829643</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath SR, Lieberman AP. The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine Disease. Frontiers in molecular neuroscience. 2017;10:78. doi: 10.3389/fnmol.2017.00078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00078</ArticleId><ArticleId IdType="pmc">PMC5360718</ArticleId><ArticleId IdType="pubmed">28381987</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickart CM. Mechanisms underlying ubiquitination. Annual review of biochemistry. 2001;70:503&#x2013;533. doi: 10.1146/annurev.biochem.70.1.503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.70.1.503</ArticleId><ArticleId IdType="pubmed">11395416</ArticleId></ArticleIdList></Reference><Reference><Citation>Malynn BA, Ma A. Ubiquitin makes its mark on immune regulation. Immunity. 2010;33:843&#x2013;852. doi: 10.1016/j.immuni.2010.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.12.007</ArticleId><ArticleId IdType="pmc">PMC3030984</ArticleId><ArticleId IdType="pubmed">21168777</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijman SM, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell. 2005;123:773&#x2013;786. doi: 10.1016/j.cell.2005.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.11.007</ArticleId><ArticleId IdType="pubmed">16325574</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel RI, et al. Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells. Oncotarget. 2015;6:4159&#x2013;4170. doi: 10.18632/oncotarget.2904.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.2904</ArticleId><ArticleId IdType="pmc">PMC4414179</ArticleId><ArticleId IdType="pubmed">25784654</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanpude P, Bhattacharya S, Dey AK, Maiti TK. Deubiquitinating enzymes in cellular signaling and disease regulation. IUBMB life. 2015;67:544&#x2013;555. doi: 10.1002/iub.1402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1402</ArticleId><ArticleId IdType="pubmed">26178252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, et al. Deubiquitinating enzymes regulate Hes1 stability and neuronal differentiation. The FEBS journal. 2015;282:2411&#x2013;2423. doi: 10.1111/febs.13290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13290</ArticleId><ArticleId IdType="pubmed">25846153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Deubiquitinating enzymes regulate PARK2-mediated mitophagy. Autophagy. 2015;11:595&#x2013;606. doi: 10.1080/15548627.2015.1034408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1034408</ArticleId><ArticleId IdType="pmc">PMC4502823</ArticleId><ArticleId IdType="pubmed">25915564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Shi W. Manipulation of viral infection by deubiquitinating enzymes: new players in host-virus interactions. Future microbiology. 2016;11:1435&#x2013;1446. doi: 10.2217/fmb-2016-0091.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2016-0091</ArticleId><ArticleId IdType="pubmed">27785925</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto M, Barca A, Lofrumento DD, Lisi S. Downstream activation of NF-kappaB in the EDA-A1/EDAR signalling in Sjogren&#x2019;s syndrome and its regulation by the ubiquitin-editing enzyme A20. Clinical and experimental immunology. 2016;184:183&#x2013;196. doi: 10.1111/cei.12764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12764</ArticleId><ArticleId IdType="pmc">PMC4837237</ArticleId><ArticleId IdType="pubmed">26724675</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlicher L, et al. SPATA2 promotes CYLD activity and regulates TNF-induced NF-kappaB signaling and cell death. EMBO reports. 2016;17:1485&#x2013;1497. doi: 10.15252/embr.201642592.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201642592</ArticleId><ArticleId IdType="pmc">PMC5048381</ArticleId><ArticleId IdType="pubmed">27458237</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, et al. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. The Journal of experimental medicine. 2014;211:313&#x2013;328. doi: 10.1084/jem.20122844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20122844</ArticleId><ArticleId IdType="pmc">PMC3920558</ArticleId><ArticleId IdType="pubmed">24493797</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli EK, et al. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. Science signaling. 2014;7:ra3. doi: 10.1126/scisignal.2004577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2004577</ArticleId><ArticleId IdType="pmc">PMC4008495</ArticleId><ArticleId IdType="pubmed">24399297</ArticleId></ArticleIdList></Reference><Reference><Citation>Pringle LM, et al. Atypical mechanism of NF-kappaB activation by TRE17/ubiquitin-specific protease 6 (USP6) oncogene and its requirement in tumorigenesis. Oncogene. 2012;31:3525&#x2013;3535. doi: 10.1038/onc.2011.520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2011.520</ArticleId><ArticleId IdType="pmc">PMC3297677</ArticleId><ArticleId IdType="pubmed">22081069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, et al. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. Journal of virology. 2013;87:4507&#x2013;4515. doi: 10.1128/JVI.00031-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00031-13</ArticleId><ArticleId IdType="pmc">PMC3624380</ArticleId><ArticleId IdType="pubmed">23388719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin R, et al. USP4 interacts and positively regulates IRF8 function via K48-linked deubiquitination in regulatory T cells. FEBS letters. 2017;591:1677&#x2013;1686. doi: 10.1002/1873-3468.12668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12668</ArticleId><ArticleId IdType="pubmed">28477415</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kao LT, Lin SJ, Wang RY, Shih SR. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PloS one. 2013;8:e63431. doi: 10.1371/journal.pone.0063431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson KM, Bhakar AL, Barker PA. TRAF6-dependent NF-kB transcriptional activity during mouse development. Developmental dynamics: an official publication of the American Association of Anatomists. 2004;231:122&#x2013;127. doi: 10.1002/dvdy.20110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.20110</ArticleId><ArticleId IdType="pubmed">15305292</ArticleId></ArticleIdList></Reference><Reference><Citation>Clague MJ, Coulson JM, Urbe S. Cellular functions of the DUBs. Journal of cell science. 2012;125:277&#x2013;286. doi: 10.1242/jcs.090985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.090985</ArticleId><ArticleId IdType="pubmed">22357969</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel E, et al. Identifying USPs regulating immune signals in Drosophila: USP2 deubiquitinates Imd and promotes its degradation by interacting with the proteasome. Cell communication and signaling: CCS. 2014;12:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4140012</ArticleId><ArticleId IdType="pubmed">25027767</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, et al. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell research. 2014;24:400&#x2013;416. doi: 10.1038/cr.2013.170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2013.170</ArticleId><ArticleId IdType="pmc">PMC3975496</ArticleId><ArticleId IdType="pubmed">24366338</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Shi W, Zhang L, Hu Z, Xu C. USP19 suppresses cellular type I interferon signaling by targeting TRAF3 for deubiquitination. Future microbiology. 2017;12:767&#x2013;779. doi: 10.2217/fmb-2017-0006.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2017-0006</ArticleId><ArticleId IdType="pubmed">28391724</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurtler C, Bowie AG. Innate immune detection of microbial nucleic acids. Trends in microbiology. 2013;21:413&#x2013;420. doi: 10.1016/j.tim.2013.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2013.04.004</ArticleId><ArticleId IdType="pmc">PMC3735846</ArticleId><ArticleId IdType="pubmed">23726320</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida R, et al. TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. The Journal of biological chemistry. 2008;283:36211&#x2013;36220. doi: 10.1074/jbc.M806576200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M806576200</ArticleId><ArticleId IdType="pmc">PMC2662295</ArticleId><ArticleId IdType="pubmed">18984593</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z, et al. Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling. The Journal of biological chemistry. 2015;290:26811&#x2013;26820. doi: 10.1074/jbc.M115.666578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.666578</ArticleId><ArticleId IdType="pmc">PMC4646334</ArticleId><ArticleId IdType="pubmed">26385923</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee NR, Kim HI, Choi MS, Yi CM, Inn KS. Regulation of MDA5-MAVS Antiviral Signaling Axis by TRIM25 through TRAF6-Mediated NF-kappaB Activation. Molecules and cells. 2015;38:759&#x2013;764. doi: 10.14348/molcells.2015.0047.</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2015.0047</ArticleId><ArticleId IdType="pmc">PMC4588718</ArticleId><ArticleId IdType="pubmed">26299329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, K.W. et al. Natural small molecule FMHM inhibits lipopolysaccharide-induced inflammatory response by promoting TRAF6 degradation via K48-linked polyubiquitination. Scientific reports5, 14715 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4589686</ArticleId><ArticleId IdType="pubmed">26423026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Ma Q, Shi H, Huo K. NUMBL interacts with TRAF6 and promotes the degradation of TRAF6. Biochemical and biophysical research communications. 2010;392:409&#x2013;414. doi: 10.1016/j.bbrc.2010.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.01.037</ArticleId><ArticleId IdType="pubmed">20079715</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z. et al. USP4 inhibits p53 and NF-kappaB through deubiquitinating and stabilizing HDAC2. Oncogene35, 2902&#x2013;2912 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4895393</ArticleId><ArticleId IdType="pubmed">26411366</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehic M, de Sa VK, Hebestreit S, Heldin CH, Heldin P. The deubiquitinating enzymes USP4 and USP17 target hyaluronan synthase 2 and differentially affect its function. Oncogenesis. 2017;6:e348. doi: 10.1038/oncsis.2017.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oncsis.2017.45</ArticleId><ArticleId IdType="pmc">PMC5519194</ArticleId><ArticleId IdType="pubmed">28604766</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao N, et al. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFalpha-induced cancer cell migration. The Biochemical journal. 2012;441:979&#x2013;986. doi: 10.1042/BJ20111358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20111358</ArticleId><ArticleId IdType="pubmed">22029577</ArticleId></ArticleIdList></Reference><Reference><Citation>Iha H, et al. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation. The EMBO journal. 2008;27:629&#x2013;641. doi: 10.1038/emboj.2008.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2008.5</ArticleId><ArticleId IdType="pmc">PMC2262037</ArticleId><ArticleId IdType="pubmed">18239685</ArticleId></ArticleIdList></Reference><Reference><Citation>Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nature reviews. Immunology. 2005;5:749&#x2013;759. doi: 10.1038/nri1703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1703</ArticleId><ArticleId IdType="pubmed">16175180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotter D, et al. Primate lentiviruses use at least three alternative strategies to suppress NF-kappaB-mediated immune activation. PLoS pathogens. 2017;13:e1006598. doi: 10.1371/journal.ppat.1006598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006598</ArticleId><ArticleId IdType="pmc">PMC5597281</ArticleId><ArticleId IdType="pubmed">28859166</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, et al. HRS plays an important role for TLR7 signaling to orchestrate inflammation and innate immunity upon EV71 infection. PLoS pathogens. 2017;13:e1006585. doi: 10.1371/journal.ppat.1006585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006585</ArticleId><ArticleId IdType="pmc">PMC5595348</ArticleId><ArticleId IdType="pubmed">28854257</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan YH, et al. USP4 targets TAK1 to downregulate TNFalpha-induced NF-kappaB activation. Cell death and differentiation. 2011;18:1547&#x2013;1560. doi: 10.1038/cdd.2011.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2011.11</ArticleId><ArticleId IdType="pmc">PMC3136563</ArticleId><ArticleId IdType="pubmed">21331078</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>